𝗥𝗲𝗱𝗯𝗲𝗿𝗿𝘆 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝘀 𝗜𝘁𝘀 𝗜𝗣 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗣𝗮𝘁𝗲𝗻𝘁𝘀 𝗚𝗿𝗮𝗻𝘁𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦, 𝗝𝗮𝗽𝗮𝗻, 𝗙𝗿𝗮𝗻𝗰𝗲, 𝗮𝗻𝗱 𝗖𝗵𝗶𝗻𝗮 At Redberry, we’ve enhanced 𝗦𝗼𝗹𝗶𝗱-𝗣𝗵𝗮𝘀𝗲 𝗖𝘆𝘁𝗼𝗺𝗲𝘁𝗿𝘆 (SPC) by addressing key limitations of first-generation systems—most notably, with our unique, proven ability to reliably and automatically distinguish viable cells from background noise in complex samples. Our core innovation lies in a 𝗽𝗮𝘁𝗲𝗻𝘁𝗲𝗱 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝘁𝗼 𝘀𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝗸𝗶𝗻𝗲𝘁𝗶𝗰𝘀, which tracks fluorescence changes in microbial cells over time. This enables precise differentiation between live microorganisms and inert or autofluorescent particles, significantly improving detection reliability. We’re proud to announce that this core technology is now protected by a strong international IP portfolio, with 𝗽𝗮𝘁𝗲𝗻𝘁𝘀 𝗴𝗿𝗮𝗻𝘁𝗲𝗱 𝗶𝗻 𝗝𝗮𝗽𝗮𝗻, 𝘁𝗵𝗲 𝗨𝗦, 𝗙𝗿𝗮𝗻𝗰𝗲, 𝗮𝗻𝗱 𝗖𝗵𝗶𝗻𝗮, and with additional geographies currently under processing. By combining this innovation with 𝗳𝘂𝗹𝗹𝘆 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝘀𝗮𝗺𝗽𝗹𝗲 𝗽𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻 and 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝗶𝗺𝗮𝗴𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀, Redberry delivers a robust, user-friendly platform for sensitive, single-cell detection—ideal for applications in water testing, pharmaceutical quality control, and cell and gene therapy (CGT). #RMM #CGT #Sterility
Very proud of the achieved work, now recognized, not only by customers but also with these granted patents. A big congrats to Joseph and the team!
Congratulations to Joseph Pierquin Jonathan Macron and your team
Operations Director at KEIKEN Engineering
2wCongratulations Jonathan Macron and Redberry SAS team!!!!!